<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="cytoa24720" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">CYTO</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10952450</article-id><article-id pub-id-type="pmcid-ver">PMC10952450.1</article-id><article-id pub-id-type="pmcaid">10952450</article-id><article-id pub-id-type="pmcaiid">10952450</article-id><article-id pub-id-type="pmid">36740883</article-id><article-id pub-id-type="doi">10.1002/cyto.a.24720</article-id><article-id pub-id-type="publisher-id">CYTOA24720</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Omip</subject></subj-group><subj-group subj-group-type="heading"><subject>Omip</subject></subj-group></article-categories><title-group><article-title>OMIP&#8208;090:&#160;A 20&#8208;parameter flow cytometry panel for rapid analysis of cell diversity and homing capacity in human conventional and regulatory <styled-content style="fixed-case" toggle="no">T</styled-content> cells</article-title><alt-title alt-title-type="left-running-head">Stroukov et al.</alt-title></title-group><contrib-group><contrib id="cytoa24720-cr-0001" contrib-type="author"><name name-style="western"><surname>Stroukov</surname><given-names initials="W">Wladislaw</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6942-3667</contrib-id><xref rid="cytoa24720-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24720-cr-0002" contrib-type="author"><name name-style="western"><surname>Mastronicola</surname><given-names initials="D">Daniela</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7922-7499</contrib-id><xref rid="cytoa24720-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24720-cr-0003" contrib-type="author"><name name-style="western"><surname>Albany</surname><given-names initials="CJ">Caraugh Jane</given-names></name><xref rid="cytoa24720-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cytoa24720-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cytoa24720-cr-0004" contrib-type="author"><name name-style="western"><surname>Catak</surname><given-names initials="Z">Zeynep</given-names></name><xref rid="cytoa24720-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24720-cr-0005" contrib-type="author"><name name-style="western"><surname>Lombardi</surname><given-names initials="G">Giovanna</given-names></name><xref rid="cytoa24720-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24720-cr-0006" contrib-type="author" corresp="yes"><name name-style="western"><surname>Scott&#224;</surname><given-names initials="C">Cristiano</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3942-5201</contrib-id><xref rid="cytoa24720-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>cristiano.scotta@kcl.ac.uk</email></address></contrib></contrib-group><aff id="cytoa24720-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">&#8220;Peter Gorer&#8221; Department of Immunobiology, School of Immunology &amp; Microbiological Sciences</named-content>
<institution>King's College London</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><aff id="cytoa24720-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences</named-content>
<institution>King's College London</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Cristiano Scott&#224;, Department of Immunobiology, School of Immunology &amp; Microbiological Sciences, 5th Floor Bermondsey Wing, Guy's Hospital,&#160;King's College London, London SE1 9RT, United Kingdom.<break/>
Email: <email>cristiano.scotta@kcl.ac.uk</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>2</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2023</year></pub-date><volume>103</volume><issue seq="60">5</issue><issue-id pub-id-type="pmc-issue-id">458263</issue-id><issue-id pub-id-type="doi">10.1002/cyto.a.v103.5</issue-id><fpage>362</fpage><lpage>367</lpage><history><date date-type="rev-recd"><day>11</day><month>1</month><year>2023</year></date><date date-type="received"><day>27</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>21</day><month>1</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>20</day><month>03</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>21</day><month>03</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-21 10:25:12.180"><day>21</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CYTO-103-362.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CYTO-103-362.pdf"/><abstract><title>Abstract</title><p>The panel was developed and optimized for monitoring changes in homing capacity and functional diversity of human CD4<sup>+</sup> conventional and regulatory T cell subsets. The analysis was based on expression of only surface markers in freshly isolated peripheral blood mononuclear cells (PBMCs) to reduce at minimum any alteration due to permeabilization or freezing/thawing procedures. We included markers to assess the distribution of na&#239;ve and memory populations based on the expression of CD45RA, CCR7, CD25, CD28 and CD95 in both conventional and regulatory T cells. The identification of major functional subsets was performed using CCR4, CCR6, CCR10, CXCR3 and CXCR5. Homing capacity of these subsets to skin, airway tract, gut and inflammatory lesions could finally be assessed with the markers CLA, CCR3, CCR5 and integrin &#946;7. The panel was tested on freshly isolated PBMCs from healthy donors and patients with allergic rhinitis or autoimmune disorders.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cytoa24720-kwd-0001">cell subpopulations</kwd><kwd id="cytoa24720-kwd-0002">cell trafficking</kwd><kwd id="cytoa24720-kwd-0003">helper T cells</kwd><kwd id="cytoa24720-kwd-0004">inflammation</kwd><kwd id="cytoa24720-kwd-0005">regulatory T cells</kwd><kwd id="cytoa24720-kwd-0006">tissue homing</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>British Heart Foundation
</institution><institution-id institution-id-type="doi">10.13039/501100000274</institution-id></institution-wrap></funding-source><award-id>FS/16/57/32733</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>King's Health Partners
</institution><institution-id institution-id-type="doi">10.13039/501100002102</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>LUPUS UK
</institution><institution-id institution-id-type="doi">10.13039/501100018817</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>National Institute for Health Research
</institution><institution-id institution-id-type="doi">10.13039/501100000272</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0005"><funding-source>Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London and the NIHR Clinical Research Facility</funding-source></award-group><award-group id="funding-0006"><funding-source><institution-wrap><institution>Wellcome Trust
</institution><institution-id institution-id-type="doi">10.13039/100010269</institution-id></institution-wrap></funding-source><award-id>108874/B/15/Z</award-id></award-group><award-group id="funding-0007"><funding-source>BD Biosciences Research Program Award</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="6"/><word-count count="3844"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.9 mode:remove_FC converted:20.03.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="cytoa24720-cit-9001"><string-name name-style="western"><surname>Stroukov</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Mastronicola</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Albany</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Catak</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Lombardi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Scott&#224;</surname><given-names>C</given-names></string-name>. <article-title>OMIP&#8208;090: A 20&#8208;parameter flow cytometry panel for rapid analysis of cell diversity and homing capacity in human conventional and regulatory <styled-content style="fixed-case" toggle="no">T</styled-content> cells</article-title>. <source>Cytometry</source>. <year>2023</year>;<volume>103</volume>(<issue>5</issue>):<fpage>362</fpage>&#8211;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.24720</pub-id><pub-id pub-id-type="pmid">36740883</pub-id><pub-id pub-id-type="pmcid">PMC10952450</pub-id></mixed-citation>
</p></notes></front><body id="cytoa24720-body-0001"><sec sec-type="background" id="cytoa24720-sec-0002"><label>1</label><title>BACKGROUND</title><p>CD4<sup>+</sup> T cells play a central role in adaptive immunity supporting an appropriate immune response to external insults by secretion of cytokines and stimulation of target cells such as CD8<sup>+</sup> T cells, B cells and innate immune cells. CD4<sup>+</sup> T cells consist of conventional T helper cells (T<sub>conv</sub> or T<sub>H</sub>), which mediate immune responses and immune&#8208;suppressive regulatory T cells (Treg) that inhibit proinflammatory effector functions and thereby limit excessive immune responses. Both, activated T<sub>reg</sub> and T<sub>conv</sub> cells further differentiate into a wide range of subsets with distinct functions and phenotypes, but exhibit considerable phenotypical and transcriptional overlap [<xref rid="cytoa24720-bib-0001" ref-type="bibr">1</xref>, <xref rid="cytoa24720-bib-0002" ref-type="bibr">2</xref>, <xref rid="cytoa24720-bib-0003" ref-type="bibr">3</xref>]. During homeostasis of the immune system T cells migrate between tissue sites via peripheral blood in order to encounter their cognate antigens [<xref rid="cytoa24720-bib-0004" ref-type="bibr">4</xref>, <xref rid="cytoa24720-bib-0005" ref-type="bibr">5</xref>, <xref rid="cytoa24720-bib-0006" ref-type="bibr">6</xref>]. In contrast, pathogenesis of autoimmune diseases can cause imbalance of these T cell subsets resulting in dysregulation and excessive reactivity of lymphocytes against autoantigens. Aberrant homing capacity of CD4<sup>+</sup> T cells can lead to accumulation of lymphocytes at auto&#8208;immune tissue sites, thereby further contributing to the loss of self&#8208;tolerance and orchestrating chronic or relapsing inflammatory responses [<xref rid="cytoa24720-bib-0007" ref-type="bibr">7</xref>, <xref rid="cytoa24720-bib-0008" ref-type="bibr">8</xref>].</p><p>Therefore, monitoring and a better understanding of phenotypic subset diversity and homing capacity of CD4<sup>+</sup> T cell subsets during disease pathogenesis can contribute to informed therapeutical decisions and can improve clinical outcomes in patients. We developed a panel for monitoring common T<sub>conv</sub> and T<sub>reg</sub> cell subsets, including populations, which have been described in context of autoimmunity and their homing capacity to skin, gut, upper airways, and inflammatory lesions based on surface markers&#160;(Table&#160;<xref rid="cytoa24720-tbl-0001" ref-type="table">1</xref>&#160;and&#160;Figure&#160;<xref rid="cytoa24720-fig-0001" ref-type="fig">1</xref>). To circumvent experimental complexity resulting from permeabilization and staining of intracellular transcription factors we focused our panel only on the staining of surface markers. This approach using combination of markers to identify CD4<sup>+</sup> T cell subsets, allows to rapidly process large quantity of patient samples and makes the panel ideal for immune monitoring uses. Note, this panel is not limited to the investigation of autoimmune and inflammatory disorders, but also applicable for transplantation studies (where homing to tissue sites might affect outcome of transplantation). This panel is also compatible with live cell sorting for further investigation of functional properties of CD4<sup>+</sup> T cell subsets.</p><table-wrap position="float" id="cytoa24720-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Summary table for application of OMIP&#8208;090.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Purpose</td><td align="left" valign="top" rowspan="1" colspan="1">Characterization of subset distribution and homing capacity in conventional and regulatory CD4<sup>+</sup> T cells using only surface markers</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Species</td><td align="left" valign="top" rowspan="1" colspan="1">Human</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell types</td><td align="left" valign="top" rowspan="1" colspan="1">Fresh PBMC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cross&#8208;reference</td><td align="left" valign="top" rowspan="1" colspan="1">OMIP&#8208;017, OMIP&#8208;018, OMIP&#8208;030, OMIP&#8208;042</td></tr></tbody></table></table-wrap><fig position="float" fig-type="FIGURE" id="cytoa24720-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Gating strategy to identify viable T<sub>reg</sub> and T<sub>conv</sub> subpopulations from total PBMC. (A) Identification of T<sub>reg</sub> and T<sub>conv</sub> cells from viable CD3<sup>+</sup>CD4<sup>+</sup> lymphocytes using surface markers CD25 and CD127. (B) T<sub>conv</sub> were further separated in na&#239;ve, follicular helper T cells (T<sub>FH</sub>) and memory T<sub>conv</sub> (i) through the expression of CD45RA, CCR7, CD28, CD95 and CXCR5. Memory T<sub>conv</sub> were further separated (ii) in the other memory Tconv subsets (TSCM, TEMRA, TCM, TTM and TEM) using the expression of CCR7 and CD28. (C) Staining of CD45RA separated na&#239;ve T<sub>reg</sub> (CD45RA<sup>+</sup>) from the other antigen experienced T<sub>reg</sub> subsets. CD45RA<sup>&#8722;</sup> T<sub>reg</sub> were further separated through the expression of CXCR5 (iii) in memory (CD45RA<sup>&#8722;</sup>CXCR5<sup>&#8722;</sup>) and follicular (T<sub>FR</sub>, CD45RA<sup>&#8722;</sup>CXCR5<sup>+</sup>) cell subsets. Alternative gating (iv) based on the combination of CD45RA and CD25 on total T<sub>reg</sub> could be used to identify the three functional subsets described by Miyara and collaborators. (D) Further gating of cells obtained in (i) (T<sub>FH</sub> and memory T<sub>conv</sub>) or (ii) (T<sub>FR</sub> and T<sub>reg</sub>) could be used to define the distribution of CCR3<sup>+</sup>, CCR5<sup>+</sup> and T<sub>H</sub> (or T<sub>H&#8208;like</sub>) cells. (E) Analysis of skin and gut homing capacity of all the subsets described in panel B, C and D (T<sub>FH</sub>, T<sub>FR</sub>, T<sub>H</sub> and T<sub>H&#8208;like</sub>) using the expression of CLA and integrin &#946;7.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="CYTO-103-362-g001.jpg"/></fig><p>Staining of viable cells for CD3, CD4, CD25 and CD127 allows to delineate between T<sub>conv</sub> (CD25<sup>&#8722;/+</sup>) and T<sub>reg</sub> cells (CD25<sup>hi</sup> CD127<sup>lo</sup>), wherein the very high expression of CD25 combined to the low expression of CD127 describe a well&#8208;defined population expressing high levels of the lineage&#8208;defining T<sub>reg</sub> marker FOXP3 [<xref rid="cytoa24720-bib-0009" ref-type="bibr">9</xref>]. Maturation of T<sub>conv</sub> cells upon recognition of their cognate antigens results in differentiation from na&#239;ve to memory and effector subsets [<xref rid="cytoa24720-bib-0010" ref-type="bibr">10</xref>]. The use of markers like CD28, CD95 and CXCR5 along to the &#8220;classical&#8221; markers CD45RA and CD197 (CCR7) allows the identification of na&#239;ve and multiple memory/effector T<sub>conv</sub> cell subsets. As a result, CD45RA<sup>+</sup> cells can be separated into na&#239;ve cells (CD45RA<sup>+</sup> CCR7<sup>+</sup> CD28<sup>+</sup> CD95<sup>&#8722;</sup>), T stem cell&#8208;like memory cells which exhibit self&#8208;renewal capacity (T<sub>SCM</sub>, CD45RA<sup>+</sup> CCR7<sup>+</sup> CD28<sup>+</sup> CD95<sup>hi</sup>) [<xref rid="cytoa24720-bib-0011" ref-type="bibr">11</xref>, <xref rid="cytoa24720-bib-0012" ref-type="bibr">12</xref>, <xref rid="cytoa24720-bib-0013" ref-type="bibr">13</xref>] and terminally differentiated effector cells (T<sub>EMRA</sub>, CD45RA<sup>+</sup> CCR7<sup>&#8722;</sup> CD28<sup>&#8722;</sup>) [<xref rid="cytoa24720-bib-0010" ref-type="bibr">10</xref>].</p><p>Gating of CD45RA<sup>&#8722;</sup> cells using the combination of CD3 and CXCR5 separates follicular helper T cells (T<sub>FH</sub>) from the other memory T cells. T<sub>FH</sub> are a specialized cell subset that supports the antibody production against pathogens. The homing marker CXCR5 mediates the migration of these cells after recognition of antigens towards germinal centres, where they interact with B cells, undergo further differentiation, and provide B cell help for induction of antibody production [<xref rid="cytoa24720-bib-0014" ref-type="bibr">14</xref>]. The other memory T cells (CXCR5<sup>&#8722;</sup>) can be further separated using the expression of CCR7 and CD28 in the three main memory populations: central memory (T<sub>CM</sub>, CD45RA<sup>&#8722;</sup> CCR7<sup>+</sup> CD28<sup>+</sup>), transitional memory (T<sub>TM</sub>, CD45RA<sup>&#8722;</sup> CCR7<sup>&#8722;</sup> CD28<sup>+</sup>) and effector memory (T<sub>EM</sub>, CD45RA<sup>&#8722;</sup> CCR7<sup>&#8722;</sup> CD28<sup>&#8722;</sup>) T<sub>conv</sub> cells.</p><p>Major T<sub>H</sub> cell subsets can be identified from either T<sub>FH</sub> (CXCR5<sup>+</sup>) or memory T cell (CXCR5<sup>&#8722;</sup>) populations according to lineage&#8208;specific cytokine secretion and the chemokine receptors CCR4 (CD194), CCR6 (CD196), CCR10 and CXCR3 (CD183) [<xref rid="cytoa24720-bib-0015" ref-type="bibr">15</xref>, <xref rid="cytoa24720-bib-0016" ref-type="bibr">16</xref>, <xref rid="cytoa24720-bib-0017" ref-type="bibr">17</xref>]. T<sub>H</sub>1 cells (CCR4<sup>&#8722;</sup> CCR6<sup>&#8722;</sup> CCR10<sup>&#8722;</sup> CXCR3<sup>+</sup>) are specified by the transcription factor T&#8208;bet and produce the pro&#8208;inflammatory cytokine IFN&#8208;&#947;, activate macrophages and mediate immunity against intracellular pathogens. T<sub>H</sub>2 cells (CCR4<sup>+</sup> CCR6<sup>&#8722;</sup> CCR10<sup>&#8722;</sup> CXCR3<sup>&#8722;</sup>) orchestrate defense against large extracellular pathogens and helminths by secretion of IL&#8208;4, but are also involved in inflammatory disorders, such as asthma and allergies [<xref rid="cytoa24720-bib-0018" ref-type="bibr">18</xref>]. IL&#8208;9 producing T<sub>H</sub>9 cells (CCR4<sup>&#8722;</sup> CCR6<sup>+</sup> CCR10<sup>&#8722;</sup> CXCR3<sup>+</sup>) can be induced by the growth factor TGF&#8208;&#946; and IL&#8208;4 from T<sub>H</sub>2 cells and are similarly involved in immunity against intestinal helminths and onset of allergies [<xref rid="cytoa24720-bib-0019" ref-type="bibr">19</xref>]. The transcription factor ROR&#947;T specifies the IL&#8208;17 producing T<sub>H</sub>17 cell subset (CCR4<sup>+</sup> CCR6<sup>+</sup> CCR10<sup>&#8722;</sup> CXCR3<sup>&#8722;</sup>), which mediate protection against fungi and extracellular bacteria [<xref rid="cytoa24720-bib-0020" ref-type="bibr">20</xref>, <xref rid="cytoa24720-bib-0021" ref-type="bibr">21</xref>]. Further, balance of T<sub>H</sub>17 cells and T<sub>reg</sub> cells plays a critical role in onset of autoimmune diseases [<xref rid="cytoa24720-bib-0022" ref-type="bibr">22</xref>, <xref rid="cytoa24720-bib-0023" ref-type="bibr">23</xref>, <xref rid="cytoa24720-bib-0024" ref-type="bibr">24</xref>]. Plasticity within the T<sub>H</sub>17 subset leads co&#8208;expression of markers and functional properties that are shared between subsets. Indeed, in some conditions, ROR&#947;T<sup>+</sup> T<sub>H</sub>17 cells can start expressing T&#8208;bet, CXCR3 and secrete both IL&#8208;17 and IFN&#8208;&#947;. This subset (T<sub>H</sub>1&#8208;like T<sub>H</sub>17 cells) might represent an intermediate and transitional state during trans&#8208;differentiation between T<sub>H</sub>1 and T<sub>H</sub>17 cells [<xref rid="cytoa24720-bib-0025" ref-type="bibr">25</xref>]. T<sub>H</sub>22 (CCR4<sup>+</sup> CCR6<sup>+</sup> CCR10<sup>+</sup> CXCR3<sup>&#8722;</sup>) are characterized by secretion of the eponymous cytokine IL&#8208;22 and TNF&#8208;&#945;, and are involved in skin immunity and maintenance [<xref rid="cytoa24720-bib-0026" ref-type="bibr">26</xref>].</p><p>Similarly, T<sub>reg</sub> cells can be separated into different stages of differentiation using CD45RA and CD25 markers. The level of expression of these two molecules can be used to identify the three functional subsets described by Miyara and collaborators: na&#239;ve (population I, CD45RA<sup>+</sup> CD25<sup>+</sup>), effector (population II, CD45RA<sup>&#8722;</sup> CD25<sup>hi</sup>) and cytokine&#8208;producing (population III, CD45RA<sup>&#8722;</sup> CD25<sup>+</sup>) T<sub>reg</sub> cells [<xref rid="cytoa24720-bib-0003" ref-type="bibr">3</xref>, <xref rid="cytoa24720-bib-0027" ref-type="bibr">27</xref>]. Besides, T<sub>reg</sub> cells exhibit phenotypical and transcriptional overlap with the T<sub>conv</sub> cells they target, therefore the same markers can be used to distinguish follicular regulatory (T<sub>FR</sub>) and T<sub>H</sub>&#8208;like subsets within the T<sub>reg</sub> compartment [<xref rid="cytoa24720-bib-0001" ref-type="bibr">1</xref>, <xref rid="cytoa24720-bib-0002" ref-type="bibr">2</xref>, <xref rid="cytoa24720-bib-0028" ref-type="bibr">28</xref>]. To explore subset diversity of T<sub>reg</sub> cells, we set and adjusted the gates on clear populations of CD45RA<sup>&#8722;</sup> memory T<sub>conv</sub> cells across multiple donors and subsequently applied the same gates to either T<sub>FR</sub> or memory T<sub>reg</sub> cells.</p><p>Both chronic inflammatory diseases and autoimmune disorders can exhibit localized inflammation at various tissue sites. Inflammation is often mediated by the recruitment of T cells into these tissues. Migration is regulated by the expression of specific homing receptors that mediate rolling of T cells over activated endothelial cells and their trafficking into the tissue. We included the cutaneous lymphocyte antigen (CLA) as a crucial marker for initiation of skin homing of lymphocytes, which is associated with T cell mediated cutaneous inflammation [<xref rid="cytoa24720-bib-0029" ref-type="bibr">29</xref>, <xref rid="cytoa24720-bib-0030" ref-type="bibr">30</xref>]. To identify lymphocytes homing to small intestine we used the expression of integrin &#946;7 [<xref rid="cytoa24720-bib-0031" ref-type="bibr">31</xref>]. Staining of CCR3 for the recognition of T cells accumulating in the upper airway mucosa and involved in asthma and allergic inflammation [<xref rid="cytoa24720-bib-0032" ref-type="bibr">32</xref>, <xref rid="cytoa24720-bib-0033" ref-type="bibr">33</xref>]. Finally, we also included the staining of CCR5 that is expressed on activated T cells involved in several pathological processes including autoimmunity, cancer, and HIV infection [<xref rid="cytoa24720-bib-0034" ref-type="bibr">34</xref>]. Its expression drives T cells to atherosclerotic plaques [<xref rid="cytoa24720-bib-0035" ref-type="bibr">35</xref>] and, in combination with CXCR3, to inflammatory lesions in autoimmune diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and multiple sclerosis (MS) [<xref rid="cytoa24720-bib-0036" ref-type="bibr">36</xref>, <xref rid="cytoa24720-bib-0037" ref-type="bibr">37</xref>]&#160;(Table&#160;<xref rid="cytoa24720-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="cytoa24720-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Reagents used in OMIP&#8208;090.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Reagent specificity</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clone</th><th align="left" valign="bottom" rowspan="1" colspan="1">Fluorochrome</th><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">CD3</td><td align="left" valign="top" rowspan="1" colspan="1">UCHT1</td><td align="left" valign="top" rowspan="1" colspan="1">AF 700</td><td align="left" valign="top" rowspan="1" colspan="1">T cell Lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD4</td><td align="left" valign="top" rowspan="1" colspan="1">SK3</td><td align="left" valign="top" rowspan="1" colspan="1">BUV 395</td><td align="left" valign="top" rowspan="1" colspan="1">T helper Lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD25</td><td align="left" valign="top" rowspan="1" colspan="1">M&#8208;A251</td><td align="left" valign="top" rowspan="1" colspan="1">PE/CF594</td><td align="left" valign="top" rowspan="1" colspan="1">T<sub>reg</sub> Lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD127</td><td align="left" valign="top" rowspan="1" colspan="1">HIL&#8208;7R&#8208;M21</td><td align="left" valign="top" rowspan="1" colspan="1">BV 786</td><td align="left" valign="top" rowspan="1" colspan="1">T<sub>reg</sub> Lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD45RA</td><td align="left" valign="top" rowspan="1" colspan="1">HI100</td><td align="left" valign="top" rowspan="1" colspan="1">BUV 496</td><td align="left" valign="top" rowspan="1" colspan="1">Na&#239;ve/memory</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD28</td><td align="left" valign="top" rowspan="1" colspan="1">CD28.2</td><td align="left" valign="top" rowspan="1" colspan="1">BV 711</td><td align="left" valign="top" rowspan="1" colspan="1">Cell subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD95</td><td align="left" valign="top" rowspan="1" colspan="1">DX2</td><td align="left" valign="top" rowspan="1" colspan="1">BUV 737</td><td align="left" valign="top" rowspan="1" colspan="1">Cell subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR3</td><td align="left" valign="top" rowspan="1" colspan="1">5E8</td><td align="left" valign="top" rowspan="1" colspan="1">BV 510</td><td align="left" valign="top" rowspan="1" colspan="1">Homing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR4 (CD194)</td><td align="left" valign="top" rowspan="1" colspan="1">1G1</td><td align="left" valign="top" rowspan="1" colspan="1">BV 605</td><td align="left" valign="top" rowspan="1" colspan="1">Cell subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR5</td><td align="left" valign="top" rowspan="1" colspan="1">J418F1</td><td align="left" valign="top" rowspan="1" colspan="1">PE/Cy7</td><td align="left" valign="top" rowspan="1" colspan="1">Activation/Homing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR6 (CD196)</td><td align="left" valign="top" rowspan="1" colspan="1">G034E3</td><td align="left" valign="top" rowspan="1" colspan="1">APC</td><td align="left" valign="top" rowspan="1" colspan="1">Cell subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR7 (CD197)</td><td align="left" valign="top" rowspan="1" colspan="1">G043H7</td><td align="left" valign="top" rowspan="1" colspan="1">BV 421</td><td align="left" valign="top" rowspan="1" colspan="1">Differentiation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR10</td><td align="left" valign="top" rowspan="1" colspan="1">1B5</td><td align="left" valign="top" rowspan="1" colspan="1">PerCP/Cy5.5</td><td align="left" valign="top" rowspan="1" colspan="1">Cell subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CXCR3 (CD183)</td><td align="left" valign="top" rowspan="1" colspan="1">1C6/CXCR3</td><td align="left" valign="top" rowspan="1" colspan="1">PE/Cy5</td><td align="left" valign="top" rowspan="1" colspan="1">Cell subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CXCR5 (CD185)</td><td align="left" valign="top" rowspan="1" colspan="1">J252D4</td><td align="left" valign="top" rowspan="1" colspan="1">PE</td><td align="left" valign="top" rowspan="1" colspan="1">Homing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Integrin Beta 7</td><td align="left" valign="top" rowspan="1" colspan="1">FIB504</td><td align="left" valign="top" rowspan="1" colspan="1">BV 650</td><td align="left" valign="top" rowspan="1" colspan="1">Homing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CLA</td><td align="left" valign="top" rowspan="1" colspan="1">HECA&#8208;452</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">Homing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fixable Viability Stain 780</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">Live/Dead Near Infra&#8208;Red (NIR)</td><td align="left" valign="top" rowspan="1" colspan="1">Viability/Dump</td></tr></tbody></table></table-wrap></sec><sec id="cytoa24720-sec-0003"><label>2</label><title>SIMILARITY TO PUBLISHED <styled-content style="fixed-case" toggle="no">OMIPS</styled-content>
</title><p>This OMIP is similar to OMIP&#8208;017, &#8208;018, &#8208;30 and &#8208;42 in their objective to identify multiple human T cells subsets in PBMCs using exclusively surface receptors [<xref rid="cytoa24720-bib-0012" ref-type="bibr">12</xref>, <xref rid="cytoa24720-bib-0015" ref-type="bibr">15</xref>, <xref rid="cytoa24720-bib-0016" ref-type="bibr">16</xref>, <xref rid="cytoa24720-bib-0017" ref-type="bibr">17</xref>]. However, in OMIP&#8208;17 and &#8208;18 there is no possibility to characterize any regulatory T cell subsets. The above similar OMIPs do not investigate cell trafficking to non&#8208;lymphoid tissues (i.e., skin, gut, or airway mucosa).</p></sec><sec id="cytoa24720-sec-0004"><label>3</label><title>ETHICAL USE OF HUMAN SAMPLES</title><p>All procedures performed on human participants were in accordance with the ethical standards of the Helsinki Declaration and ethically approved by HRA and Health and Care Research Wales (HCRW) with IRAS project ID 236524, REC reference 18/LO/1814. Informed consent was obtained from all individual participants involved in the study.</p></sec><sec sec-type="COI-statement" id="cytoa24720-sec-0006"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec id="cytoa24720-sec-0007"><sec disp-level="2" id="cytoa24720-sec-0008"><title>PEER REVIEW</title><p>The peer review history for this article is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://publons.com/publon/10.1002/cyto.a.24720" ext-link-type="uri">https://publons.com/publon/10.1002/cyto.a.24720</ext-link>.</p></sec></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="cytoa24720-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>MIFlowCyt:</bold> MIFlowCyt Item Checklist</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-103-362-s002.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="cytoa24720-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Data S1:</bold> Supporting Information</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-103-362-s001.docx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="cytoa24720-sec-0005"><title>ACKNOWLEDGMENTS</title><p>This research was supported by the British Heart Foundation, King's Health Partners, Wellcome Trust PhD studentship (grant number 108874/B/15/Z), Lupus UK, BD Biosciences Research Program Award,&#160;National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London and the NIHR Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.</p></ack><ref-list id="cytoa24720-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="cytoa24720-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0001"><string-name name-style="western"><surname>Halim</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Romano</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>McGregor</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Correa</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Pavlidis</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Grageda</surname><given-names>N</given-names></string-name>, et al. <article-title>An atlas of human regulatory T helper&#8208;like cells reveals features of Th2&#8208;like Tregs that support a tumorigenic environment</article-title>. <source>Cell Rep</source>. <year>2017</year>;<volume>20</volume>:<fpage>757</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.06.079</pub-id><pub-id pub-id-type="pmid">28723576</pub-id><pub-id pub-id-type="pmcid">PMC5529316</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0002"><string-name name-style="western"><surname>Duhen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Duhen</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>DJ</given-names></string-name>. <article-title>Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells</article-title>. <source>Blood</source>. <year>2012</year>;<volume>119</volume>:<fpage>4430</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2011-11-392324</pub-id><pub-id pub-id-type="pmid">22438251</pub-id><pub-id pub-id-type="pmcid">PMC3362361</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0003"><string-name name-style="western"><surname>Giganti</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Atif</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mohseni</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Mastronicola</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Grageda</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Povoleri</surname><given-names>GAM</given-names></string-name>, et al. <article-title>Treg cell therapy: how cell heterogeneity can make the difference</article-title>. <source>Eur J Immunol</source>. <year>2021</year>;<volume>51</volume>:<fpage>39</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201948131</pub-id><pub-id pub-id-type="pmid">33275279</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0004"><string-name name-style="western"><surname>Krummel</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Bartumeus</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>G&#233;rard</surname><given-names>A</given-names></string-name>. <article-title>T cell migration, search strategies and mechanisms</article-title>. <source>Nat Rev Immunol</source>. <year>2016</year>;<volume>16</volume>:<fpage>193</fpage>&#8211;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2015.16</pub-id><pub-id pub-id-type="pmid">26852928</pub-id><pub-id pub-id-type="pmcid">PMC4869523</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0005"><string-name name-style="western"><surname>Matsushima</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Takashima</surname><given-names>A</given-names></string-name>. <article-title>Bidirectional homing of Tregs between the skin and lymph nodes</article-title>. <source>J Clin Invest</source>. <year>2010</year>;<volume>120</volume>:<fpage>653</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1172/JCI42280</pub-id><pub-id pub-id-type="pmid">20179349</pub-id><pub-id pub-id-type="pmcid">PMC2827968</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0006"><string-name name-style="western"><surname>Tomura</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Honda</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Tanizaki</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Otsuka</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Egawa</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Tokura</surname><given-names>Y</given-names></string-name>, et al. <article-title>Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice</article-title>. <source>J Clin Invest</source>. <year>2010</year>;<volume>120</volume>:<fpage>883</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1172/JCI40926</pub-id><pub-id pub-id-type="pmid">20179354</pub-id><pub-id pub-id-type="pmcid">PMC2827959</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0007"><string-name name-style="western"><surname>Mellado</surname><given-names>M</given-names></string-name>. <article-title>T cell migration in rheumatoid arthritis</article-title>. <source>Front Immunol</source>. <year>2015</year>;<volume>6</volume>:<elocation-id>384</elocation-id>. <pub-id pub-id-type="doi">10.3389/fimmu.2015.00384</pub-id><pub-id pub-id-type="pmid">26284069</pub-id><pub-id pub-id-type="pmcid">PMC4515597</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0008"><string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Harada</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Juang</surname><given-names>Y&#8208;T</given-names></string-name>, <string-name name-style="western"><surname>Kyttaris</surname><given-names>VC</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zidanic</surname><given-names>M</given-names></string-name>, et al. <article-title>Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus</article-title>. <source>J Immunol</source>. <year>2007</year>;<volume>178</volume>:<fpage>1938</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.3.1938</pub-id><pub-id pub-id-type="pmid">17237445</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0009"><string-name name-style="western"><surname>Seddiki</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Santner&#8208;Nanan</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Martinson</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zaunders</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sasson</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Landay</surname><given-names>A</given-names></string-name>, et al. <article-title>Expression of interleukin (IL)&#8208;2 and IL&#8208;7 receptors discriminates between human regulatory and activated T cells</article-title>. <source>J Exp Med</source>. <year>2006</year>;<volume>203</volume>:<fpage>1693</fpage>&#8211;<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20060468</pub-id><pub-id pub-id-type="pmid">16818676</pub-id><pub-id pub-id-type="pmcid">PMC2118333</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0010"><string-name name-style="western"><surname>Mahnke</surname><given-names>YD</given-names></string-name>, <string-name name-style="western"><surname>Brodie</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lugli</surname><given-names>E</given-names></string-name>. <article-title>The who's who of T&#8208;cell differentiation: human memory T&#8208;cell subsets</article-title>. <source>Eur J Immunol</source>. <year>2013</year>;<volume>43</volume>:<fpage>2797</fpage>&#8211;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201343751</pub-id><pub-id pub-id-type="pmid">24258910</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0011"><string-name name-style="western"><surname>Maecker</surname><given-names>HT</given-names></string-name>, <string-name name-style="western"><surname>McCoy</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Nussenblatt</surname><given-names>R</given-names></string-name>. <article-title>Standardizing immunophenotyping for the human immunology project</article-title>. <source>Nat Rev Immunol</source>. <year>2012</year>;<volume>12</volume>:<fpage>191</fpage>&#8211;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1038/nri3158</pub-id><pub-id pub-id-type="pmid">22343568</pub-id><pub-id pub-id-type="pmcid">PMC3409649</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0012"><string-name name-style="western"><surname>Mahnke</surname><given-names>YD</given-names></string-name>, <string-name name-style="western"><surname>Beddall</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>. <article-title>OMIP&#8208;017: human CD4+ helper T&#8208;cell subsets including follicular helper cells</article-title>. <source>Cytom Part A</source>. <year>2013</year>;<volume>83 A</volume>:<fpage>439</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.22269</pub-id><pub-id pub-id-type="pmcid">PMC4347402</pub-id><pub-id pub-id-type="pmid">23450796</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0013"><string-name name-style="western"><surname>Gattinoni</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Lugli</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Ji</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Pos</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Paulos</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Quigley</surname><given-names>MF</given-names></string-name>, et al. <article-title>A human memory T cell subset with stem cell&#8208;like properties</article-title>. <source>Nat Medi</source>. <year>2011</year>;<volume>17</volume>:<fpage>1290</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2446</pub-id><pub-id pub-id-type="pmcid">PMC3192229</pub-id><pub-id pub-id-type="pmid">21926977</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0014"><string-name name-style="western"><surname>Kerfoot</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Yaari</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Gonzalez</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Kleinstein</surname><given-names>SH</given-names></string-name>, et al. <article-title>Germinal center B cell and T follicular helper cell development initiates in the Interfollicular zone</article-title>. <source>Immunity</source>. <year>2011</year>;<volume>34</volume>:<fpage>947</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2011.03.024</pub-id><pub-id pub-id-type="pmid">21636295</pub-id><pub-id pub-id-type="pmcid">PMC3280079</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0015"><string-name name-style="western"><surname>Brodie</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Brenna</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></string-name>. <article-title>OMIP&#8208;018: chemokine receptor expression on human T helper cells</article-title>. <source>Cytom Part A</source>. <year>2013</year>;<volume>83 A</volume>:<fpage>530</fpage>&#8211;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.22278</pub-id><pub-id pub-id-type="pmid">23504907</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0016"><string-name name-style="western"><surname>Wingender</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Kronenberg</surname><given-names>M</given-names></string-name>. <article-title>OMIP&#8208;030: characterization of human T cell subsets via surface markers</article-title>. <source>Cytom Part A</source>. <year>2015</year>;<volume>87</volume>:<fpage>1067</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.22788</pub-id><pub-id pub-id-type="pmid">26506224</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0017"><string-name name-style="western"><surname>Staser</surname><given-names>KW</given-names></string-name>, <string-name name-style="western"><surname>Eades</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Karpova</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>DiPersio</surname><given-names>JF</given-names></string-name>. <article-title>OMIP&#8208;042: 21&#8208;color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood</article-title>. <source>Cytom Part A</source>. <year>2018</year>;<volume>93</volume>:<fpage>186</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.23303</pub-id><pub-id pub-id-type="pmcid">PMC6077845</pub-id><pub-id pub-id-type="pmid">29288606</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0018"><string-name name-style="western"><surname>Walker</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>McKenzie</surname><given-names>ANJ</given-names></string-name>. <article-title>TH2 cell development and function</article-title>. <source>Nat Rev Immunol</source>. <year>2018</year>;<volume>18</volume>:<fpage>121</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2017.118</pub-id><pub-id pub-id-type="pmid">29082915</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0019"><string-name name-style="western"><surname>Veldhoen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Uyttenhove</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>van Snick</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Helmby</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Westendorf</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Buer</surname><given-names>J</given-names></string-name>, et al. <article-title>Transforming growth factor&#8208;&#946; &#8220;reprograms&#8221; the differentiation of T helper 2 cells and promotes an interleukin 9&#8208;producing subset</article-title>. <source>Nat Immunol</source>. <year>2008</year>;<volume>9</volume>:<fpage>1341</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1659</pub-id><pub-id pub-id-type="pmid">18931678</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0020"><string-name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></string-name>, <string-name name-style="western"><surname>McKenzie</surname><given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Tadokoro</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Lepelley</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lafaille</surname><given-names>JJ</given-names></string-name>, et al. <article-title>The orphan nuclear receptor ROR&#947;t directs the differentiation program of Proinflammatory IL&#8208;17+ T helper cells</article-title>. <source>Cell</source>. <year>2006</year>;<volume>126</volume>:<fpage>1121</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.07.035</pub-id><pub-id pub-id-type="pmid">16990136</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0021"><string-name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zielinski</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></string-name>. <article-title>Human Th17 subsets</article-title>. <source>Eur J Immunol</source>. <year>2012</year>;<volume>42</volume>:<fpage>2215</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201242741</pub-id><pub-id pub-id-type="pmid">22949319</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0022"><string-name name-style="western"><surname>Noack</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Miossec</surname><given-names>P</given-names></string-name>. <article-title>Th17 and regulatory T cell balance in autoimmune and inflammatory diseases</article-title>. <source>Autoimmun Rev</source>. <year>2014</year>;<volume>13</volume>:<fpage>668</fpage>&#8211;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2013.12.004</pub-id><pub-id pub-id-type="pmid">24418308</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0023"><string-name name-style="western"><surname>Eisenstein</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>CB</given-names></string-name>. <article-title>The Treg/Th17 cell balance: a new paradigm for autoimmunity</article-title>. <source>Pediatr Res</source>. <year>2009</year>;<volume>65</volume>:<fpage>26</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e31819e76c7</pub-id><pub-id pub-id-type="pmid">19218879</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0024"><string-name name-style="western"><surname>Lee</surname><given-names>GR</given-names></string-name>. <article-title>The balance of th17 versus treg cells in autoimmunity</article-title>. <source>Int J Mol Sci</source>. <year>2018</year>;<volume>19</volume>:<fpage>1</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3390/ijms19030730</pub-id><pub-id pub-id-type="pmcid">PMC5877591</pub-id><pub-id pub-id-type="pmid">29510522</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0025"><string-name name-style="western"><surname>Cohen</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Crome</surname><given-names>SQ</given-names></string-name>, <string-name name-style="western"><surname>MacDonald</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Dai</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Mager</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Levings</surname><given-names>MK</given-names></string-name>. <article-title>Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci</article-title>. <source>J Immunol</source>. <year>2011</year>;<volume>187</volume>:<fpage>5615</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1101058</pub-id><pub-id pub-id-type="pmid">22048764</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0026"><string-name name-style="western"><surname>Eyerich</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Eyerich</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Pennino</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Carbone</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Nasorri</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Pallotta</surname><given-names>S</given-names></string-name>, et al. <article-title>Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling</article-title>. <source>J Clin Invest</source>. <year>2009</year>;<volume>2</volume>:<fpage>198</fpage>&#8211;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1172/JCI40202</pub-id><pub-id pub-id-type="pmcid">PMC2786807</pub-id><pub-id pub-id-type="pmid">19920355</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0027"><string-name name-style="western"><surname>Miyara</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yoshioka</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kitoh</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Shima</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Wing</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Niwa</surname><given-names>A</given-names></string-name>, et al. <article-title>Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor</article-title>. <source>Immunity</source>. <year>2009</year>;<volume>30</volume>:<fpage>899</fpage>&#8211;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1016/J.IMMUNI.2009.03.019</pub-id><pub-id pub-id-type="pmid">19464196</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0028"><string-name name-style="western"><surname>Levine</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Medoza</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hemmers</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Moltedo</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Niec</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Schizas</surname><given-names>M</given-names></string-name>, et al. <article-title>Stability and function of regulatory T cells expressing the transcription factor T&#8208;bet</article-title>. <source>Nature</source>. <year>2017</year>;<volume>546</volume>:<fpage>421</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/nature22360</pub-id><pub-id pub-id-type="pmid">28607488</pub-id><pub-id pub-id-type="pmcid">PMC5482236</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0029"><string-name name-style="western"><surname>Berg</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Yoshino</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Rott</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Warnock</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Kishimoto</surname><given-names>TK</given-names></string-name>, et al. <article-title>The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell&#8208;leukocyte adhesion molecule 1</article-title>. <source>J Exp Med</source>. <year>1991</year>;<volume>174</volume>:<fpage>1461</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1084/jem.174.6.1461</pub-id><pub-id pub-id-type="pmid">1720810</pub-id><pub-id pub-id-type="pmcid">PMC2119052</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0030"><string-name name-style="western"><surname>Ferran</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Romeu</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Rinc&#243;n</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sagrist&#224;</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gim&#233;nez Arnau</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Celada</surname><given-names>A</given-names></string-name>, et al. <article-title>Circulating CLA+ T lymphocytes as peripheral cell biomarkers in T&#8208;cell&#8208;mediated skin diseases</article-title>. <source>Exp Dermatol</source>. <year>2013</year>;<volume>22</volume>:<fpage>439</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1111/exd.12154</pub-id><pub-id pub-id-type="pmid">23800052</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0031"><string-name name-style="western"><surname>Fern&#225;ndez&#8208;Guti&#233;rrez</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>De Miguel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Morado</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hern&#225;ndez&#8208;Garcia</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Banares</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jover</surname><given-names>JA</given-names></string-name>. <article-title>Defective early T and T&#8208;dependent B cell activation in systemic lupus erythematosus</article-title>. <source>Lupus</source>. <year>1998</year>;<volume>7</volume>:<fpage>314</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1191/096120398678920226</pub-id><pub-id pub-id-type="pmid">9696135</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0032"><string-name name-style="western"><surname>Danilova</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Skrindo</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Gran</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Hales</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Jahnsen</surname><given-names>J</given-names></string-name>, et al. <article-title>A role for CCL28&#8208;CCR3 in T&#8208;cell homing to the human upper airway mucosa</article-title>. <source>Mucosal Immunol</source>. <year>2015</year>;<volume>8</volume>:<fpage>107</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2014.46</pub-id><pub-id pub-id-type="pmid">24917456</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0033"><string-name name-style="western"><surname>Erin</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Barnes</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Hansel</surname><given-names>TT</given-names></string-name>. <article-title>Eotaxin receptor (CCR3) antagonism in asthma and allergic disease</article-title>. <source>Curr Drug Targets Inflamm Allergy</source>. <year>2002</year>;<volume>1</volume>:<fpage>201</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.2174/1568010023344715</pub-id><pub-id pub-id-type="pmid">14561201</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0034"><string-name name-style="western"><surname>Viola</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Luster</surname><given-names>AD</given-names></string-name>. <article-title>Chemokines and their receptors: drug targets in immunity and inflammation</article-title>. <source>Annu Rev Pharmacol Toxicol</source>. <year>2008</year>;<volume>48</volume>:<fpage>171</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.48.121806.154841</pub-id><pub-id pub-id-type="pmid">17883327</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0035"><string-name name-style="western"><surname>Komissarov</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Potashnikova</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Freeman</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Gontarenko</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Maytesyan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Lederman</surname><given-names>MM</given-names></string-name>, et al. <article-title>Driving T cells to human atherosclerotic plaques: CCL3/CCR5 and CX3CL1/CX3CR1 migration axes</article-title>. <source>Eur J Immunol</source>. <year>2021</year>;<volume>51</volume>:<fpage>1857</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/eji.202049004</pub-id><pub-id pub-id-type="pmid">33772780</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0036"><string-name name-style="western"><surname>Qin</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rottman</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Myers</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Kassam</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Weinblatt</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Loetscher</surname><given-names>M</given-names></string-name>, et al. <article-title>The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions</article-title>. <source>J Clin Invest</source>. <year>1998</year>;<volume>101</volume>:<fpage>746</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1172/JCI1422</pub-id><pub-id pub-id-type="pmid">9466968</pub-id><pub-id pub-id-type="pmcid">PMC508621</pub-id></mixed-citation></ref><ref id="cytoa24720-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="cytoa24720-cit-0037"><string-name name-style="western"><surname>Balashov</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Rottman</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Weiner</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Hancock</surname><given-names>WW</given-names></string-name>. <article-title>CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP&#8208;1&#945; and IP&#8208;10 are expressed in demyelinating brain lesions</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1999</year>;<volume>96</volume>:<fpage>6873</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.12.6873</pub-id><pub-id pub-id-type="pmid">10359806</pub-id><pub-id pub-id-type="pmcid">PMC22009</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>